“We are very pleased that Marc Scheineson has joined Alston & Bird,” said Alston & Bird Managing Partner
The announcement comes on the heels of the firm’s appointment of such notables as former United States Senator
Mr. Scheineson has been involved in some of the highest profile regulatory matters at the FDA including Canadian imports, fast tracking reviews, prolonging product exclusivity and streamlining the FDA regulatory process. Also, representing some of the United States’ largest pharmaceutical and medical device manufacturers, he has handled a broad spectrum of extremely sophisticated products in obtaining marketing clearance and approval from the FDA. Experience in other cutting-edge regulatory issues include the protection of human research subjects, clinical trial law, anti-kickback rules for promoting medical products to physicians, and the Health Insurance Portability & Accountability Act of 1996 (HIPAA) privacy regulation.
Mr. Scheineson joins Alston & Bird’s nationally recognized
Frequently quoted as an expert on the FDA’s regulatory practices, Mr. Scheineson is a drug and device lawyer with more than 20 years of experience. At the FDA he was involved in many innovations including: prescription drug user fees, debarment, medical device amendments and nutritional labeling. He is a graduate of the University of Cincinnati College of Law, where he received his J.D., and Georgetown University Law Center where he received an LL.M.